comparemela.com
Home
Live Updates
Making COPD a public health priority starts here: understanding the condition : comparemela.com
Making COPD a public health priority starts here: understanding the condition
A recent poll* of 14,890 members of the public in 14 countries underscores the need for greater awareness and prioritization of evidence-based COPD care.
Related Keywords
Spain
,
Belgium
,
Geneva
,
Genè
,
Switzerland
,
Canada
,
United States
,
Canadian
,
Mohamed Azmi Ahmad Hassali
,
Ahmad Salman
,
Hyder Ali
,
Sameen Abbas
,
Shahid Shah
,
Sohail Ayaz Muhammad
,
Expert Review Of Pharmacoeconomics Outcomes Research
,
International Respiratory Coalition
,
World Economic Forum
,
Communicable Diseases Ncds Initiative
,
International Coalition Of Respiratory Nurses
,
Lancet Commission
,
Canadian Institute For Health Information
,
International Federation Of Ageing
,
International Pharmaceutical Federation
,
Policymaker Survey Respondent
,
National Trends
,
Astrazeneca
,
Global Allergy Airways Patient Platform
,
European Commission
,
Global Quality
,
Healthier Together
,
Communicable Diseases
,
Joint Declaration
,
Global Allergy
,
Airways Patient Platform
,
International Federation
,
International Coalition
,
Respiratory Nurses
,
Lancet Respiratory
,
Disease Control
,
Chronic Obstructive Pulmonary Disease
,
Global Economic Burden
,
World Economic
,
Hospital Stays
,
Irfhan Ali Bin Hyder
,
Expert Review
,
Standards Position Statements
,
Healthy System Policy Changes
,
General Practice Based Population
,
Chronic Obstructive Pulmonary
,
One Year Mortality
,
Their Predictors
,
Patients Hospitalized
,
Nationwide Population Based
,
First Year After Hospitalization
,
Advocacy
,
Air Pollution
,
Certification And Standards
,
Climate Change
,
Footprint
,
Global Health
,
Health Care
,
Health Systems
,
History
,
Hospitals
,
Industry
,
Italy
,
Medicines
,
Parliament
,
Patients
,
Platforms
,
Policy
,
Poll
,
Pollution
,
Prevention
,
Public Health
,
Research
,
Risk And Compliance
,
South Korea
,
United Kingdom
,
comparemela.com © 2020. All Rights Reserved.